Maud Velev, Barouyr Baroudjian, Roxane Pruvost, Eleonora De Martin, Ariane Laparra, Samy Babai, Sandra Teysseire, François-Xavier Danlos, Laurence Albiges, Charlotte Bernigaud, Marc-Antoine Benderra, Pauline Pradère, Mohamad Zaidan, Chantal Decroisette, Fatma Fallah, Gaelle Matergia, Pernelle Lavaud, Hélène Jantzem, Marina Atzenhoffer, Véronique Buyse, Samy Ammari, Caroline Robert, Stéphane Champiat, Sabine Messayke, Aurélien Marabelle, Catherine Guettier, Céleste Lebbe, Olivier Lambotte, Jean-Marie Michot
BACKGROUND: Generalised oedema was occasionally reported associated with immune checkpoint inhibitors (ICPIs). The purpose of this study is to investigate immune-related generalised oedema (ir-GE) drug related to ICPI, through frequency, clinical and pathological characteristics, and patient's outcome. PATIENTS AND METHODS: Objectives of the study were to report on ir-GE associated with ICPI to define frequency, associated signs and symptoms, pathological characteristics, severity, and response to corticosteroids...
January 2023: European Journal of Cancer